As of 4:00pm ET
| +1.24 / +6.37%|
The 7 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 24.00, with a high estimate of 30.00 and a low estimate of 16.00. The median estimate represents a +15.94% increase from the last price of 20.70.
The current consensus among 9 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.